ACOUSIA.COM: Keyword Density Checker

Total words: 2579 | 2-word phrases: 663 | 3-word phrases: 744 | 4-word phrases: 790

PAGE INFO

Title	Try to keep the title under 60 characters (34 characters) Home › Acousia Therapeutics GmbH
Description	Try to keep the meta description between 50 - 160 characters (173 characters) Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany, dedicated to identify small molecules for an innovative treatment of hearing loss.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	poc preclinical phase	9	1.21%
2	invivo poc preclinical	9	1.21%
3	i phase ii	9	1.21%
4	preclinical phase i	9	1.21%
5	phase i phase	9	1.21%
6	sensorineural hearing loss	5	0.67%
7	hearing loss a	5	0.67%
8	hearing loss snhl	5	0.67%
9	enhance and preserve	4	0.54%
10	of hearing loss	4	0.54%
11	programs news contact	4	0.54%
12	and preserve natural	4	0.54%
13	chronic hearing loss	3	0.40%
14	natural hearing in	3	0.40%
15	make hearing loss	3	0.40%
16	acou082 invivo poc	3	0.40%
17	approach programs news	3	0.40%
18	preserve natural hearing	3	0.40%
19	in patients with	3	0.40%
20	discovery acou082 invivo	3	0.40%
21	small molecule drug	3	0.40%
22	agerelated hearing loss	3	0.40%
23	phase ii hearing	2	0.27%
24	striving to keep	2	0.27%
25	ci surgery hearing	2	0.27%
26	surgery hearing preservation	2	0.27%
27	to keep people	2	0.27%
28	cisplatin induced hearing	2	0.27%
29	damage to the	2	0.27%
30	loss discovery acou082	2	0.27%

#	Keyword	Frequency	Density
1	phase i phase ii	9	1.14%
2	poc preclinical phase i	9	1.14%
3	invivo poc preclinical phase	8	1.01%
4	preclinical phase i phase	8	1.01%
5	sensorineural hearing loss snhl	5	0.63%
6	and preserve natural hearing	3	0.38%
7	approach programs news contact	3	0.38%
8	acou082 invivo poc preclinical	3	0.38%
9	make hearing loss a	3	0.38%
10	enhance and preserve natural	3	0.38%
11	preserve natural hearing in	3	0.38%
12	loss discovery acou082 invivo	2	0.25%
13	with agerelated hearing loss	2	0.25%
14	hearing loss discovery acou082	2	0.25%
15	about approach programs news	2	0.25%
16	dual mode of action	2	0.25%
17	programs news contact menu	2	0.25%
18	of all hearing loss	2	0.25%
19	that enhance and preserve	2	0.25%
20	with sensorineural hearing loss	2	0.25%
21	compounds that enhance and	2	0.25%
22	patients with sensorineural hearing	2	0.25%
23	ci surgery hearing preservation	2	0.25%
24	striving to keep people	2	0.25%
25	small molecule drug candidates	2	0.25%
26	develop novel compounds that	2	0.25%
27	novel compounds that enhance	2	0.25%
28	discovery acou082 invivo poc	2	0.25%
29	news contact menu about	2	0.25%
30	patients with agerelated hearing	2	0.25%
31	hearing aid synergistic enhancement	2	0.25%
32	acou085 invivo poc preclinical	2	0.25%
33	hearing loss a treatable	2	0.25%
34	first patient enrolled in	2	0.25%
35	patient enrolled in its	2	0.25%
36	enrolled in its phase	2	0.25%
37	hearing loss company acousia	2	0.25%
38	in its phase 2	2	0.25%
39	discovery acou085 invivo poc	2	0.25%
40	on its path to	2	0.25%

#	URL	Whois	Check
1	https://acousia.right.berlin/contact/privacy/	Whois	right.berlin
2	https://acousia.right.berlin/contact/privacy/	Whois	right.berlin
3	https://acousia.right.berlin/contact/imprint/	Whois	right.berlin